| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8679428 | Thrombosis Research | 2018 | 6 Pages |
Abstract
LA diagnostics should, under DOAC therapy, be limited to situations in which time-critical evaluation is warranted. It is crucial to take into account the finding that even samples containing DOAC concentrations below the limit of detection of the drugs may lead to false-positive DRVVT measurements.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
T. Flieder, M. Weiser, Th. Eller, M. Dittrich, K. von Bargen, S. Alban, J. Kuhn, C. Knabbe, I. Birschmann,